title: Utilisation of amino acid mixtures in adolescents with phenylketonuria.
abstract: The nutritional regimen of patients with phenylketonuria (PKU) comprises a diet of natural proteins and phenylalanine (Phe)-free amino acid (AA) mixture. The main daily protein requirement is covered by a Phe-free AA mixture. In an adult with PKU, the consumption of the daily AA requirement in one single dose at breakfast caused nausea and vomiting. Therefore, four studies were designed to investigate the adverse and metabolic effects resulting from large intakes of AA mixtures used in the treatment of PKU patients with respect to the following: (1) biochemical effects following consumption of one single dose of Phe-free AA mixture in healthy persons; (2) transient metabolic changes caused by different individual regimens of AA intake in healthy persons and in one PKU patient; (3) nitrogen excretion in PKU patients taking the AA mixture in two or three portions; and (4) catabolic metabolism of AA in a PKU patient. In healthy subjects following the ingestion of the AA mixture in one bolus there was an increase in the blood levels of the given AA and also an increase in blood insulin concentration and a decrease in blood glucose concentration. These changes were less marked when the AA mixture was divided into three portions per day. In contrast, in a PKU patient following the ingestion of AA there was an increase in blood glucose. The urinary nitrogen excretion was greater in PKU patients when one compared to three portions of AA mixture was taken. The consumption of the daily requirement of AA mixture in one single does produced increased catabolism in a PKU patient. In conclusion it is recommended that the total daily amount of AA mixture should be divided into a minimum of three portions.
authors.affiliation: Department of Paediatrics, Virchow-Klinikum, Humboldt University, Berlin, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Mönch
authors.forename: M E
authors.initials: ME
authors.lastname: Herrmann
authors.forename: H
authors.initials: H
authors.lastname: Brösicke
authors.forename: A
authors.initials: A
authors.lastname: Schöffer
authors.forename: M
authors.initials: M
authors.lastname: Keller
mesh_terms: D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000008:administration & dosage*; D001120:Arginine / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D018753:Diet, Protein-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage*; D006801:Humans; D007328:Insulin / Q000097:blood; D019344:Lactic Acid / Q000097:blood; D007930:Leucine / Q000097:blood; D010661:Phenylketonurias / Q000178:diet therapy* / Q000378:metabolism*
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D004044:Dietary Proteins; D007328:Insulin; D019344:Lactic Acid; D001120:Arginine; D007930:Leucine